Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Spoelstra

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Hormones & Cancer|February 15, 2017
MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer ProgressionJessica L Christenson, Kiel T Butterfield, Nicole S Spoelstra, et al.
The Journal of Investigative Dermatology|March 31, 2015
Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte PrecursorsNathaniel B Goldstein, Maranke I Koster, Laura G Hoaglin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive diseaseMeenakshi Singh, Nicole S Spoelstra, Annie Jean, et al.
Molecular Cancer Therapeutics|October 18, 2012
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxelDiana M Cittelly, Irina Dimitrova, Erin N Howe, et al.
Cancer Research|May 18, 2017
Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast CancerValerie N Barton, Jessica L Christenson, Michael A Gordon, et al.
Molecular Cancer Therapeutics|February 26, 2015
Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivoValerie N Barton, Nicholas C D'Amato, Michael A Gordon, et al.
Molecular Cancer Therapeutics|March 16, 2021
Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast CancerJessica L Christenson, Kathleen I O'Neill, Michelle M Williams, et al.
Cells|February 11, 2023
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast CancerNatalia B Fernández, Sofía M Sosa, Justin T Roberts, et al.
Breast Cancer Research and Treatment|March 11, 2008
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistanceDjuana M E Harvell, Nicole S Spoelstra, Meenakshi Singh, et al.
Development (Cambridge, England)|October 13, 2016
Constitutive expression of microRNA-150 in mammary epithelium suppresses secretory activation and impairs de novo lipogenesisRichard E Heinz, Michael C Rudolph, Palani Ramanathan, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Hormones & Cancer|February 15, 2017
MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer ProgressionJessica L Christenson, Kiel T Butterfield, Nicole S Spoelstra, et al.
The Journal of Investigative Dermatology|March 31, 2015
Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte PrecursorsNathaniel B Goldstein, Maranke I Koster, Laura G Hoaglin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive diseaseMeenakshi Singh, Nicole S Spoelstra, Annie Jean, et al.
Molecular Cancer Therapeutics|October 18, 2012
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxelDiana M Cittelly, Irina Dimitrova, Erin N Howe, et al.
Cancer Research|May 18, 2017
Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast CancerValerie N Barton, Jessica L Christenson, Michael A Gordon, et al.
Molecular Cancer Therapeutics|February 26, 2015
Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivoValerie N Barton, Nicholas C D'Amato, Michael A Gordon, et al.
Molecular Cancer Therapeutics|March 16, 2021
Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast CancerJessica L Christenson, Kathleen I O'Neill, Michelle M Williams, et al.
Cells|February 11, 2023
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast CancerNatalia B Fernández, Sofía M Sosa, Justin T Roberts, et al.
Breast Cancer Research and Treatment|March 11, 2008
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistanceDjuana M E Harvell, Nicole S Spoelstra, Meenakshi Singh, et al.
Development (Cambridge, England)|October 13, 2016
Constitutive expression of microRNA-150 in mammary epithelium suppresses secretory activation and impairs de novo lipogenesisRichard E Heinz, Michael C Rudolph, Palani Ramanathan, et al.
Pageof 5